Abstract

Prophylactic DLI transfusion following allogeneic HSCT remains a safe and effective treatment for pediatric patients with AL and can reduce post-transplant relapse and improve long-term survival.

Affiliated Institutions

Related Publications

Publication Info

Year
2025
Type
article
Citations
0
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

0
OpenAlex

Cite This

Ang Wei, Chenguang Jia, Guanghua Zhu et al. (2025). Prophylactic donor lymphocyte infusions after first allogeneic hematopoietic stem cell transplantation in children with acute leukemia. Blood Research . https://doi.org/10.1007/s44313-025-00111-4

Identifiers

DOI
10.1007/s44313-025-00111-4